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The thyroid hormones (THs) triiodothyronine (T3) and tetraio-
dothyronine, or thyroxine (T4), not only dramatically impact on
development and differentiation, but also on the sexual and
reproductive function. There is large body of literature, in fact, on
the effects of THs on the reproductive function in both humans
(Poppe and Velkeniers, 2004; Wajner et al., 2009) and animals
(Hapon et al., 2010; Nelson et al., 2011).
For a long time the gonads were thought to be unresponsive to
THs, but TH receptors (TR) were discovered in rat (Jannini et al.,
1990; Palmero et al., 1988) and then in human testis (Jannini
et al., 2000). In women, the association of menstrual disturbance
with thyroid disease was described as early as 1840 by von Base-
dow, but the discovery of TRs in the ovary was carried out at the
end of last century (Wakim et al., 1994b). Therefore, the link be-
tween thyroid and reproductive function was well established.
Since then, research has shown that thyroid dysfunction is associ-
ated with an adverse effect on fertility, both in men (Wagner et al.,
2009) and women (Dittrich et al., 2011). There is also evidence that
THs can affect the sex steroid hormone axis (Bagamasbad and
Denver, 2011), consequently sexual hormones and the pituitary
gland can mediate the action of THs on the reproductive
physiology.
While the effects of THs on fertility have been widely studied,
little is known about their influence on sexual function. In the last
few years, an increasing number of evidences have shown the in-
fluence of THs on male sexual function, particularly on ejaculation
control as well on desire and erectile function (Carani et al., 2005;
Corona et al., 2012b; Di Sante et al., 2016). The female sexual
function and the relationship with thyroid function is still less
studied. Furthermore, studies conducted on animals have shown
the presence of TRs in the male (Carosa et al., 2010) and female
genitalia (Rodriguez-Castelan et al., 2017). Moreover, knockout
mice for TRs showed alterations in sexual behavior (Dellovade et al.,
2000).
The purpose of this review is to summarize and discuss the
available data on the influence of THs on male and female sexual
function to understand the molecular mechanisms of the influence
of the thyroid gland on sexual behavior and function.
2. Thyroid hormones and thyroid hormone receptors
TH action is mainly dependent on the binding of the cognate
with specific receptors, the most important being at nuclear level
(Mendoza and Hollenberg, 2017). Thyroid hormone receptors (TRs)
belong to the steroid/thyroid receptors superfamily that evolved
from a single ancestor gene (Carosa et al., 1998; Kostrouch et al.,
1998). TRa and TRb are the product of two distinct genes that are
further differentially spliced into TRa1, TRa2 (Jannini et al., 1992; Sap
et al., 1986; Weinberger et al., 1986), and TRb1 and TRb2 (Lazar et al.,
1988; Mitsuhashi et al., 1988). TRa1 and TRb1 are widely expressed
and act as thyroid hormone-dependent transcription factors,inducing or repressing gene expression in response to T3. The
differentially spliced product TRa2 does not bind the hormone and
exerts a dominant negative effect on the action of other TRs (Katz
et al., 1995; Koenig et al., 1989). Although two different genes
encode the two TR isoforms, they share a very high degree of
structural homology and the more conserved part of protein is the
DNA binding domain (Fig. 1). On the DNA, TRs recognize the
sequence AGGTCA, to which they can bind as a monomer. In the
thyroid responsive element (TRE) of the promoters of responsive
genes this sequence is repeated with a space of 4 bp to permit the
DNA bind of the heterodimer TR/retinoid X receptor (RXR). The
presence of RXR increases the binding affinity (Lazar, 2003).
Thyroid hormones are hydrophobic and for a long time it was
thought they entered the cytoplasm by passive diffusion. In recent
years, it has become clear that this is not the case and several TH
transport proteins have been identified (Friesema et al., 2003;
Schweizer et al., 2014). To date, the most clinically relevant THs
transporter is the monocarboxylate transporter 8 (MCT8), which is
associated with a THs insensibility syndrome (Schwartz et al.,
2005). It is now clear that TH transporters can modulate the real
effect of THs because they regulate, at the tissue level, the avail-
ability of THs. Deeping onTHs transporters is beyond the purpose of
this review, but the future will show if their alterations may involve
sexual function. Here we can highlight that MCT8 is expressed both
in the testis and in the ovary (Friesema et al., 2003; Romano et al.,
2017).
Inside cells, THs bind TRs to regulate target gene expression. The
interaction of T3 with the ligand domain induces a conformation
change of the hormone-binding pocket. The change of conforma-
tion appears to be critical for the release of corepressor and the
recruitment of coactivators on the regulated gene's promoters. In
the classic view (Fig. 2), T3 action is based on its positive effect on
target genes. In the absence of T3, the TRs recruit a multiprotein
complex that includes nuclear corepressors, which in turn recruit
histone deacetylase 3 (HDAC3) and other proteins to mediate
transcriptional repression via histone deacetylation (Sun et al.,
2013; You et al., 2013). The presence of T3 leads to dismissal of
Fig. 2. Classical view of THs action. The interaction of T3 with TH induces the release of
corepressor and the recruitment of coactivators on the regulated gene's promoters. In
the absence of T3 the TRs recruit a multiprotein complex that includes nuclear co-
repressors, which in turn recruit HDAC3 and other proteins to mediate transcriptional
repression via histone deacetylation.
E. Carosa et al. / Molecular and Cellular Endocrinology 467 (2018) 49e59 51the corepressor complex and recruitment coregulators that induce
histone acetylation and transcriptional activation. Some recent
studies, based on chromatin affinity precipitation (ChAP)-seq and
DNase hypersensitivity analysis showed extensive chromatin
remodeling in the presence of T3 stimulation in accord with the
classical model of THs action (Ayers et al., 2014; Chatonnet et al.,
2012; Grontved et al., 2015; Ramadoss et al., 2014). These studies
have also established that RXR overlaps TR DNA binding, endorsing
the fact that TRs act like heterodimers with retinoid X receptor
(RXR) (Ramadoss et al., 2014). New studies demonstrated that the
molecular mechanisms of T3 actions are more complicated and the
classical model does not explain the exact mechanism of action; in
particular, the T3 negative regulation remains a paradox, in the liver
TRs down-regulate more genes in the presence of T3 than they
activate. Several hypotheses have been suggested to explain the
molecular mechanism of T3 negative gene regulation. One of these
asserts the possibility that coregulators act as a repressor on pro-
moters of negative regulated genes (Costa-e-Sousa & Hollenberg,
2012), but it is possible that numerous models will be required to
explain the exact molecular mechanism of TRs action. To support
the direct effects of THs on sexual function it is important to
demonstrate that TRs are expressed in male and female genitalia.3. Thyroid hormone receptors expression in sexual organs
3.1. Male
3.1.1. Thyroid hormone receptors in testis
T3 regulates the maturation and growth of the testis, controlling
Sertoli and, with much lower impact, Leydig cell proliferation and
differentiation during testicular development in human and other
mammalian species (Francavilla et al., 1991; Holsberger and Cooke,
2005; Jannini et al., 1999; Mendis-Handagama and Siril Ariyaratne,
2005). The first study describing the selective presence of specific
TH nuclear binding sites in Sertoli cells of developing rat testis
opened a new research avenue (Jannini et al., 1990), since these
findings changed the classical view of the testis as a thyroid unre-
sponsive organ (Barker and Klitgaard, 1952). Ontogenetic expres-
sion of TRs in human and in rat testis established that the fetal and
prepubertal ages of Sertoli cells represent the period of maximal
expression, but the binding capacity is not completely absent in the
adult (Buzzard et al., 2000; Canale et al., 2001; Jannini et al, 1993,
1995, 1999, 2000; Tagami et al., 1990; Ulisse et al., 1992). In rats,
TRs were present in different testicular cell types and their
expression changes during testis maturation (Table 1). TRa1
expression was very high in Sertoli cells during their proliferativephase, until day 15 post-natal, then decreases and remains very low
in adulthood (Jannini et al, 1994, 1999). TRa1 was also found in
spermatogenic germ cells from intermediate spermatogonia to
mid-cycle pachytene spermatocytes (Buzzard et al., 2000), as well
in the interstitial compartment in immature testis, probably in the
Leydig cells, but at very low levels (Buzzard et al., 2000). The same
laboratoy found that the TRb1 expression in immature Sertoli cells
and spermatogenic germ cells was also very low in relation to TRa1
expression. This confirmed our findings, which previously showed
that TRb mRNA is below the threshold of detectability of both
Northern and ribonuclease (RNase) protection analyses (Jannini
et al., 1995). In fact, Palmero et al. (1995) demonstrated that TRb1
is detectable only after 30 cycles of PCR amplification. According to
our evidences using biochemical and molecular techniques of
detection of TRs, studies on transgenic mice lacking either TRa or
TRb have shown that the effect of T3 on Sertoli cell proliferation is
mediated through TRa isoform (Holsberger et al., 2005). Further-
more, Fumel et al. (2015), using a TRa dominant negative isoform
selectively expressed in Sertoli and Leydig cells, confirmed the role
of TRa1 in Sertoli cells during post-natal life and pointed out that T3
does not regulate steroidogenic activity in a direct manner on
Leydig cells, also fitting the spatio-temporal distribution of TRs
previously demonstrated. Thyroid hormonesmodulates the activity
of glucose transporters and aromatase in Sertoli cells to regulate the
function of seminiferous epithelium (Carosa et al., 2005; Ulisse
et al., 1994, 1998).
3.1.2. Thyroid hormone receptors in epididymis
The presence of TRa1 and b1 isoforms was more recently
demonstrated in epithelial cells derived from adult rat epididymis
(De Paul et al., 2008) (Table 1). However, further studies are
necessary to understand the role of TRs, if any, in epididymis
function in light of the fact that TR proteins are localized in the
cytosol of the cells, suggesting a possible active role for THs in the
epithelial cells of epididymis acting through a non-genomic fashion
(Bassett et al., 2003).
3.1.3. Thyroid hormone receptors in corpora cavernosa
All isoforms of TRs, i.e. a1, a2 and b1 are expressed in rat and
human penis (Table 1). In particular, TRa1 and TRa2 are present from
perinatal to adult age, while the b1 form is almost entirely absent in
fetal cells while present in the adult. Immunohistochemistry ex-
periments using an anti-TRa1 antibody demonstrated a widespread
staining for this TR in both endothelial and muscular cells of the
corpora cavernosa and corpus spongiosum of the human adult
penis (Carosa et al., 2010).
3.2. Female
3.2.1. Thyroid hormone receptors in ovary
Thyroid function has been associated with female reproduction
also in ancient medicine (Niazi et al., {Krassas, #9215)}, but only
very recently to the female sexual function. Thyroid diseases have
been associated with menstrual disturbance, miscarriages and
infertility (Dittrich et al., 2011; Romano et al., 1991) (Table 2).
Several studies have demonstrated the presence of TRs in all ovary
cell types. TRa1 and b1 are expressed in primordial, primary and
secondary follicles (Aghajanova et al., 2009), and they are also
present in follicular fluid and in granulosa cells (Aghajanova et al.,
2009; Wakim et al., 1993, 1994b). Mature oocytes from women
undergoing IVF express TRa1, TRa2, TRb1, and TRb2 mRNA, thus
supporting the hypothesis that T3 has a direct effect on the human
oocyte (Stavreus Evers, 2012; Zhang et al., 1997). Furthermore, the
corpus luteum of rats, cows and rabbits shows immunostaining for
all isoforms of TRs (Aghajanova et al., 2011; Fedail et al., 2014;
Table 1
Thyroid hormone nuclear receptors (TRs) Expression in male genital tissues.
Tissue/Cell Type Receptor isoform Expression References
Fetal/Pre- pubertal Adult
Whole testis TRa1 þþ þ (Jannini et al., 1999) (Buzzard et al., 2000; Jannini et al., 2000)
TRa2 þþ þþ (Buzzard et al., 2000; Jannini et al., 1999; Jannini et al., 2000)
TRb1 ± e (Buzzard et al., 2000; Jannini et al., 2000)
Sertoli cells TRa1 þþ þþ (Buzzard et al., 2000; Jannini et al., 2000)
TRa2 ? ?
TRb1 ? ± (Palmero et al., 1995)
Leydig cells TRa1 ? ± (Buzzard et al., 2000)
TRa2 ? ?
TRb1 ? ?
Germ cells TRa1 ? þ (Buzzard et al., 2000)
TRa2 ? ?
TRb1 ? ± (Buzzard et al., 2000)
Epididymis TRa1 ? þ (De Paul et al., 2008)
TRa2 ? ?
TRb1 ? þ (De Paul et al., 2008)
Penis TRa1 þþ þþ (Carosa et al., 2010)
TRa2 þþ þþ (Carosa et al., 2010)
TRb1 e þþ (Carosa et al., 2010)
Table 2






Ovary Stroma TRa1 þþ (Rodriguez-Castelan et al., 2017) (Aghajanova et al., 2009; Wakim et al., 1994b)
Epithelium TRa2 þþ (Rodriguez-Castelan et al., 2017)
Primary follicle TRb1 þþ (Aghajanova et al., 2009; Rodriguez-Castelan et al., 2017) (Wakim et al., 1994b)
Corpus luteus TRa1 þþ (Rodriguez-Castelan et al., 2017) (Stavreus Evers, 2012) (Navas et al., 2014) (Stavreus Evers, 2012)
TRa2 þþ
TRb1 þþ
Oviduct TRa1 þþ (Rodriguez-Castelan et al., 2017)
TRa2 þþ
TRb1 þþ
Uterus Endometrium TRa1 þþ (Rodriguez-Castelan et al., 2017) (Aghajanova et al., 2011) (Stavreus Evers, 2012)
TRa2 þ (Aghajanova et al., 2011)
TRb1 þþ (Rodriguez-Castelan et al., 2017) (Aghajanova et al., 2011) (Aghajanova et al., 2011) (Stavreus Evers,
2012)
Myometrium TRa1 þ (Rodriguez-Castelan et al., 2017) (Hulchiy et al., 2012)
TRa2 þ (Rodriguez-Castelan et al., 2017)










TRa1 þþ (Rodriguez-Castelan et al., 2017)
TRa2 þþ
TRb1 þþ
E. Carosa et al. / Molecular and Cellular Endocrinology 467 (2018) 49e5952Rodriguez-Castelan et al., 2017). Positive staining of ovarian stromal
cells and in ovarian surface epithelium was also observed for both
TRa1 and b1 (Aghajanova et al., 2009; Wakim et al., 1994a).3.2.2. Thyroid hormone receptors in oviduct
Papers that have studied the presence of TRs in oviduct are
scarce. The presence of TRa1 was described in the epithelium and
smooth musculature of ampulla and isthmus in rat (Navas et al.,
2014) (Table 2). Recently, the expression of all TR isoforms was
shown in the luminal and glandular epithelium and in smooth
muscle cells of whole oviductal regions in rabbit (Rodriguez-
Castelan et al., 2017).3.2.3. Thyroid hormone receptors in uterus
Extensive studies were conducted in uterus during the normal
menstrual cycle (Aghajanova et al., 2011) and during pregnancy
(Stavreus Evers, 2012). The localization of TRa1 and TRb1 has been
found in the luminal epithelium, glandular epithelium and stromaof human endometrium throughout menstrual cycle (Aghajanova
et al., 2011), however no staining was present for the a2 isoform
(Table 2). Despite the fact that the presence of binding sites for T3 in
the myometrium was shown in 1983 (Kirkland et al., 1983), only in
recent years has TRa1 been described in the myometrium from
macaques (Hulchiy et al., 2012), rats (Navas et al., 2014), and rabbits
(Rodriguez-Castelan et al., 2017).3.2.4. Thyroid hormone receptors in vagina
The presence of TRs in the vagina has been studied very recently
(Rodriguez-Castelan et al., 2017) (Table 2). Both the vaginal
epithelium and the smooth and striated musculatures of all por-
tions of the vagina were positive for TRa1-2 and b1. Notably, the
positive immunostaining for all TR isoforms are found in smooth
muscle cells of the corpus cavernosum of the clitoris and the
epithelial cells of the Skens's gland, both involved in the female
pleasure (Jannini et al., 2014). This finding is interesting because it
reveals an additional connection between male and female
E. Carosa et al. / Molecular and Cellular Endocrinology 467 (2018) 49e59 53genitalia. Indeed, the presence of TRs in the erectile tissues of men
and women could emphasize a similar involvement of T3 action in
the sexual function of both genders.3.3. Brain
The brain may also be considered a sexual organ for regulating
sexual desire and arousal (Ciocca et al., 2016). TH actions in the
brain are extremely complex because they are fundamentals for
brain development (Moog et al.). Indeed, hypothyroidism during
fetal life is associated with cretinism, a severe form of mental
retardation (Bernal, 2007). The expression of TRs in the brain has
been extensively studied inmammalians: inmouse brain, TRs a and
b isoforms are expressed in almost all parts of the brain with an
overlapping distribution. Some differences between a and b iso-
form expression are observed in the hippocampus, amygdala and
hypothalamus (Fig. 3) (Bernal, 2000).
In the human brain, TR mRNAs are detected at around 8 weeks
of gestation (Iskaros et al., 2000). Concerning the receptor protein,
there is only one study in which receptor concentrations were
quantitated by ligand-binding assays (Bernal and Pekonen, 1984).
The receptor protein concentration was found to be very low at 10
weeks of gestation, and increased by a factor of 10 up to the 16th
week, coinciding with the period of neuroblast multiplication.
During this time, the brain gains in weight and DNA content by
about five-fold, so that the total brain T3 receptor content increases
500 times. This coincides with the period of active neuroblast
proliferation (Dobbing and Sands, 1970). In neural cell cultures, T3
receptors have been detected in neurons, astrocytes and oligo-
dendrocytes (Luo et al., 1986; Yusta et al., 1988).Fig. 4. Prevalence of sexual dysfunction in men with thyroid diseases. Modified from
Carani et al. (2005).4. Thyroid and sexual function in male
The association between thyroid diseases and sexual dysfunc-
tion in men has not been systematically studied until recently.
Indeed, in the last 10 years, an increasing number of studies have
correlated different aspects of sexual performance and thyroid
functions. The first report that demonstrated a close correlation
between specific sexual disorders in males with thyroid hypo- and
hyperfunction was published in 2005 (Carani et al., 2005). In this
study four major sexual alterations e HSDD (hypoactive sexual
desire disorder), PE (premature ejaculation), DE (delayedFig. 3. TRs expression in mouse brain (Bernal, 2000). This image has been made freely ava
viewed at http://creativecommons.org/licenses/by-nc-nd/2.0/.ejaculation), and ED (erectile dysfunctions) ewere associated with
hyper- or hypothyroid status (Fig. 4). The main sexological
complaint found in that study in hyperthyroid patients was PE,
whereas in hypothyroid subjects, it was DE. Remarkably, both
ejaculatory dysfunctions very frequently reverted uponilable under a Creative Commons (CC-BY-NC-ND) license. A copy of the license can be
E. Carosa et al. / Molecular and Cellular Endocrinology 467 (2018) 49e5954achievement of euthyroidism in the absence of any other treatment
for the sexual symptom. Although these can be considered sec-
ondary effects of treatment on mood, such a response on PE and DE
was beyond all expectations, suggesting a direct involvement of
thyroid hormones on the physiology of ejaculation. Now, it is
known that TRs are located in themale genitals (Carosa et al., 2010),
so it can be hypothesized a direct T3 effect on erectile tissues and
smooth muscle cells of the genital tract. Nevertheless, the molec-
ular mechanisms involved in the T3 action at this level remain
unclear. Below we report all the evidences published to date about
the influence of T3 on the various aspects of male sexual function.
4.1. Thyroid and ejaculation
Several studies have confirmed the strong association between
DE and PE with hypothyroidism and hyperthyroidism (Carani et al.,
2005; Cihan et al., 2009a; Corona et al., 2011, 2012a, 2006b),
respectively. This connection has been widely documented both in
animal models and humans (Cahangirov et al., 2011; Cihan et al.,
2009b). Cahangirov el al. (Cahangirov et al., 2011) demonstrated
that hyperthyroidism in rats increases seminal vesicle contraction
frequency and bulbospongiosus muscle contractile activity, which
indicates that hyperthyroidism can affect ejaculatory emission and
expulsion phases. In that study, after a 28-day washout period (to
determine spontaneous recovery from hyperthyroidism) the
aforementioned alterations were reversed, confirming the direct
role of THs in the control of ejaculation. These results have been
replicated in several clinical studies in humanpatients (Carani et al.,
2005; Cihan et al., 2009a). In a series of 755 consecutive men
seeking medical care for sexual dysfunction, including PE, the
prevalence of suppressed thyroid-stimulating hormone (TSH),
which is a marker of possible hyperthyroidism, was twofold higher
in patients with PE than those reporting normal ejaculatory timing
(Corona et al., 2004). A recent study in a Turkish population
essentially confirms an association between the hyperthyroid state
and PE, which was substantially ameliorated by therapy for the
thyroid disease (Cihan et al., 2009a). However, and not surprisingly,
Waldinger did not find any association between TSH levels and
intravaginal ejaculation latency time (IELT) in a cohort of Dutch
subjects (Waldinger et al., 2005) with lifelong PE, which logically
suggests that the association with hyperthyroidism is restricted to
the acquired type of PE. In light of all these reports, hyperthyroid-
ism should be considered a novel and reversible etiological risk
factor for PE, and TH disorders should be suspected, by simple
physical examination, in the case of ejaculatory disorders (Jannini
et al, 2011, 2015; McMahon et al., 2013; Sansone et al., 2015).
We found high prevalence of DE in hypothyroid patients, 64.3%
(Carani et al., 2005) (Fig. 4). Furthermore, TSH levels were positively
related to reported ejaculatory latencies (Corona et al., 2011). In
patients with hypothyroidism, a resolution of DE was obtained in
half of the subjects after thyroid hormone normalization (Carani
et al., 2005) (Fig. 4). The view that thyroid hormones regulate the
ejaculatory reflex is emerging and hypothyroidism should be ruled
out in each patient with DE as recommended by International So-
ciety of Sexual Medicine (ISSM) guidelines (Corona et al., 2016).
Hence, the view that thyroid hormones regulate the ejaculatory
reflex is consistently emerging (Di Sante et al., 2016).
4.2. Thyroid and erectile dysfunction
Anecdotal reports suggest that ED is frequent (up to 70%) in men
with hyperthyroidism (Meikle, 2004). Small studies in Italian and
Greek patients with thyroid dysfunction found that both hypo-
thyroidism and hyperthyroidism can be associated with ED and
that the correction of the underlying thyroid conditions frequentlyrestores erectile function (Fig. 4) (Carani et al., 2005) (Krassas et al.,
2008). In Krassas et al.’s replication study (Krassas et al., 2008), 63%
and 70% of the hypo- and hyperthyroid subjects, respectively, have
some form of ED compared with 34% of the control group. While
the prevalence of ED in hypothyroidism was similar in previous
Carani et al.’s study (64% Carani et al., 2005), the reported number
of hyperthyroid subjects with a pathological score of International
Index of Erectile Function (IIEF) was lower (15%). In contrast,
Veronelli et al. (2006) showed that 59% of men with thyroid
problems had ED; interestingly, this result did not change when
adjusted for age, suggesting that TH were more important than age
in ED. A more recent study (Krysiak et al., 2017) documented that
men with overt hypothyroidism obtained lower scores in all five
domains of IIEF, while menwith subclinical hypothyroidism only in
erectile function domain. L-thyroxine treatment improved erectile
function and normalized intercourse satisfaction, orgasmic func-
tion, sexual desire and overall satisfaction in the formed group, as
well as normalized erectile function in the latter. To date, no in-
formation on the prevalence of thyroid dysfunction in ED men is
available either for the general population or for men seeking
medical help for sexual problems. Further research is required to
understand the nature of the link between thyroid disorders and
ED; for nowwe can only emphasize that both a and b TRs have been
described in rat and human corpora cavernosa endothelial and
smooth muscle cells (Carosa et al., 2010; Owen et al., 2007). Studies
in animal models of hyperthyroidism indicate an impairment of
nitric oxide (NO)-dependent relaxation of corpora cavernosa (Hu
et al., 2009; Ozdemirci et al., 2001). In rabbit corpora cavernosa
strips, both acetylcholine- and electrical field stimulation-induced
relaxation were impaired, whereas sensitivity to a NO donor, so-
dium nitroprusside, was unchanged (Ozdemirci et al., 2001). These
data suggest an effect of thyroid hormones in penile NO formation,
which has been demonstrated in a rat model (Hu et al., 2009). It is
therefore possible that hyperthyroidism-associated ED could be
due to a direct effect of TH on their cognate receptors.
4.3. Thyroid and hypoactive sexual desire
We found that low sexual desire may be related to hypothy-
roidism and can be normalized by TH therapy (Carani et al., 2005)
(Fig. 4). The underlying pathogenic mechanisms have not been
completely clarified. It is possible that a hypothyroidism-induced
prolactin rise could mediate these negative effects on sexual
desire. However, a direct role of THs on the central nervous system
can also be hypothesized. THs are known to interfere with the
functions of the reproductive axis in men (Bagamasbad and Denver,
2011; Krassas et al., 2010), which in turn might contribute to sexual
dysfunction. Furthermore, hyperthyroidism-induced increase of
sex hormone binding globulin (SHBG), which binds androgenswith
higher affinity than estrogens, might lead to a relative hyper-
estrogenism, which, per se, can alter sexual responses. In addition,
the increase of prolactin that is often present in association with
hyperthyroidism can be associated with a decrease in libido. All
these findings demonstrate a non-controversial role of THs in hu-
man sexual dysfunction. (Maggi et al., 2013).
5. Thyroid and sexual function in female
While in male are relatively rare, thyroid hypo- and hyper-
functions are frequent in female. Thus, it is very surprisingly that
the incidence of sexual dysfunction in women with hypo- or hy-
perthyroidism is still unknown. Thyroid disorders in women are, in
fact, commonly associated with abnormalities of reproductive
physiology such as menstrual irregularities and infertility (Krassas,
2000), but sexual function has been rarely studied. For instance, the
Fig. 5. Female Sexual Functions Index (FSFI) and Beck's Depression Inventory (DBI)
questionnaire scores in womenwith thyroid diseases. Modified from (Atis et al., 2010);
(Atis et al., 2011).
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roidism has been estimated at 25e70%; ovulatory function and
fertility are also affected (Bhasin et al., 2007). Both hyper- and hy-
pothyroidism are associated with fatigue, myalgias, and mood
disturbances such as irritability and depression, which can
contribute to sexual dysfunction (Bhasin et al., 2007). Since the
incidence of hypothyroidism also peaks at the age of menopause
and perimenopausal symptoms could overlap with symptoms of
hypothyroidism, screening for hypothyroidism in women at this
age is generally recommended (Shifren and Gass, 2014). Indeed,
persistent primary hypothyroidism is occasionally associated with
hyperprolactinaemia, due to the stimulatory effect of the
thyrotropin-releasing hormone (TRH) on the production of pro-
lactin (Oppo et al., 2011). Thyroxine replacement therapy with a
return to the euthyroid state restores menstrual and ovulatory
function in most hypothyroid and hyperthyroid women, and also
normalizes prolactin levels in those with coincident hyper-
prolactinaemia (Krassas, 2000). Few studies have investigated
sexual function in women during thyroid diseases. In 2010, Atis
et al. reported that women with hyperthyroidism and hypotyr-
oidism have significantly lower female sexual function index (FSFI)
domain scores compared with age-matched healthy women (Atis
et al., 2010, 2011) (Table 3 and Fig. 5). According to the proposed
FSFI full-scale cut-off level of 26.55 (Wiegel et al., 2005), 60% of
women with hyperthyroidism in this study may have sexual
dysfunction. One study conducted by Veronelli et al. revealed that
diabetic, obese, and hypothyroidic women had a reduced score in
the FSFI questionnaire when compared with healthy women
(Veronelli et al., 2009). The same result was found by Oppo et al.
(2011), who reported that abnormal thyroid function significantly
impairs female sexual function, as assessed by the FSFI question-
naire, and that restoration of the euthyroid state is associated with
a rapid improvement of most FSFI domain scores (Oppo et al., 2011).
In addition, Oppo showed that restoration of biochemical
euthyoidism was associated with normalization of the desire,
satisfaction and pain domains, while arousal/lubrication and
orgasm remained significantly different from healthy euthyroid
controls, in spite of some improvement in orgasm.
Hyperthyroidism has been anecdotally connected in the mind of
several endocrinologists with an increase inwomen's sexual desire.
This is not the case in all studies reported, whichmirrors findings of
our report in males (Carani et al., 2005) and provides objective
evidences that untreated thyrotoxicosis is associated with impor-
tant female sexual dysfunction.
The finding that opposite endocrine conditions are associated
with similar sexual dysfunctions may appear surprising, but the
mechanisms involved in determination of sexual dysfunction in
women are complex (Ghizzani et al., 2003; Graziottin, 2003;
Jannini and Lenzi, 2003), and the role of altered thyroid status in
female sexual functions is still unclarified. However, all these
studies provide clear evidence that hyper- and hypothyroidismTable 3




Total FSFI 29 ± 10.4 24.2 ± 9.9 >0
Desire 4.3 ± 2.3 3.8 ± 2.1 >0
Arousal 4.7 ± 2.2 3.4 ± 2.3 >0
Lubrification 5.1 ± 1.6 4.3 ± 1.9 >0
Orgasm 5.1 ± 1.5 4.0 ± 2.2 >0
Satisfaction 4.9 ± 2.0 4.2 ± 1.9 >0
Pain 5.0 ± 2.6 4.4 ± 2.3 >0
BDI 11.9 ± 13.2 18.9 ± 15.4 >0markedly impair sexual function in both women as in men (Oppo
et al., 2011; Pasquali et al., 2013). Nevertheless, in women, in
whom thyroid diseases are more frequent than in men, sexual
function screening should be required (Balercia et al., 2007).
Emerging data suggests that, in women, sexual dysfunctions
may be associatedwith thyroid autoimmunity, both in the presence
of hypothyroidism and subclinical hypothyroidism (Krysiak et al.,
2016; Pasquali et al., 2013).
Autoimmunity thyroiditis diseases are common in women.
Actually, Hashimoto's thyroiditis is one of the most common hu-
man disorders, as well as the most frequent cause of hypothy-
roidism in developed countries (Caturegli et al., 2007). Several
studies showed that women with autoimmune thyroiditis,re scores, modified from Atis et al., (2010), 2011.
Control group Hypo-thyroid P
.02 32.31 ± 3.5 23.92 ± 5.18 >0.02
.05 5.16 ± 0.74 4.01 ± 0.93 >0.02
.02 5.37 ± 0.80 3.28 ± 1.30 >0.02
.02 5.40 ± 0.52 4.24 ± 0.82 >0.02
.02 5.46 ± 0.51 3.95 ± 1.23 >0.02
.02 5.40 ± 0.54 4.06 ± 0.96 >0.02
.02 5.50 ± 0.56 4.37 ± 1.14 >0.02
.02 7.82 ± 5.20 12.8 ± 7.40 >0.05
Fig. 6. Sexual behavior in female and male KO mice. Data are collected from:
(Dellovade et al., 2000; Ogawa et al, 1997, 1998, 1999, 2000; Vasudevan et al., 2013).
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cant increase in the prevalence of sexual dysfunction and displayed
a significant decrease in sexual desire (Krysiak et al., 2016; Pasquali
et al., 2013). In this respect, the availability of a shortened form of
the FSFI questionnaire (Isidori et al., 2010) in all endocrine outpa-
tient facilities would be useful to screen women with thyroid dis-
eases. However, mutatis mutandis, it should be useful to screen all
women complaining of sexual dysfunction for the presence of
thyroid hypofunction and thyroid autoimmunity.
6. Thyroid and sexual behavior
Thyroid hormone regulates various developmental and pivotal
physiological processes such as brain development. In effect, thy-
roid diseases are associated with altered mental processes in
humans. Deficiency in TH activity during the perinatal period
causes cretinism. Hypothyroidism in adults, although less dramatic,
also induces cognitive dysfunction (concentration, memory psy-
chomotor speed) and alterations in mood, with increased rates of
depressive and anxiety symptoms (Bauer et al., 2008; Heinrich and
Grahm, 2003; Sait Gonen et al., 2004). Certainly, mood alteration
correlated to thyroid dysfunction may partly justify the alterations
of sexual functions found in hyper- and hypothyroid patients,
mainly with respect to sexual desire. Several studies conducted in
animals have revealed that THs supported estrogen in the control of
sexual behavior (Bagamasbad and Denver, 2011). Estrogen plays a
critical role in reproductive development, physiology and sexual
behavior, acting in the brain, in particular in the hypothalamus. The
interplay betweenTH and estrogen actions on this brain regionmay
provide a mechanism for assessing metabolic state, thus affecting
reproductive physiology and behavior. For example, in birds and
mammals, TH promotes the transition to anestrus. In some mam-
mals, exposure to cold temperatures affects reproductive behavior,
and increases plasma TH levels, suggesting the presence of cross-
regulation between TH and estrogen (Vasudevan et al., 2002).
Molecular data have implicated that TR, specifically TRa1, inhibit
estrogen-dependent gene expression in the hypothalamus
(Vasudevan et al., 2002). Thyroid hormone administration inhibited
lordosis behavior in estrogen-primed female mice (Morgan et al.,
2000) and rats (Dellovade et al., 1996) (Fig. 6). Surprisingly, it has
been shown that female mice knockout for TRa1 (a1KO) showed
poorer lordosis than wildtype (a1WT), while female knockout for
TRb (bKO) showed greater lordosis than wildtype females (bWT)
(Dellovade et al., 2000) (Fig. 6). In agreement with those data, es-
trogen replacement plus TH treatment decreased lordosis behavior
in ovariectomized (OVX) rats and mice, compared to estrogen
replacement alone (Dellovade et al., 1996; Morgan et al., 2000).
Similarly, thyroid-intact, OVX female rats that received estrogen
replacement showed delayed onset of lordosis behavior compared
to animals that were thyroidectomized, OVX þ estrogen (Dellovade
et al., 1996), suggesting that the actions of TH on sexual behavior
are complex. Furthermore, the TRa1 isoform subtly decreases the
sexual behavior of gonadal-intact male mice (Vasudevan et al.,
2013) (Fig. 6). Several studies on estrogens regulated gene pro-
moters demonstrated that TRa1 can decrease the transcriptional
activation mediated by the estrogen receptor isoforms; this inter-
action may modulate sexual behavior in mice (Dellovade et al.,
1996; Morgan et al., 2000 Dellovade et al., 2000).
The role of sexual hormones in arousal has been defined in
humans. In the brain, estradiol synthesis increased in areas related
to sexual arousal. Furthermore, it has been described that estrogen
can sustain libido acting in the preoptic area and in the anterior
hypothalamus (Schulster et al., 2016). Actually, in men the levels of
aromatase are highest in those brain areas, where the estrogen
receptors are expressed. However, the exact role of estrogens inmale sexual function, including libido, is difficult to determine
(Carani et al., 1997; Schulster et al., 2016). In male mice, a lack of
estrogen receptors is associated with the reduction or abolition of
sexual behavior (Ogawa et al, 1997, 2000).
The above-mentioned data showed that the alteration of thyroid
function in men and women is associated with reduced sexual
desire. Animal studies show us an interaction between THs and
estrogen for sexual function regulation in the brain (Fig. 6). It is
possible to hypothesize that the genesis of HSDD in men and
womenwith thyroid diseases can be mediated by the action of THs
on estrogen regulated genes in the hypothalamus (Schulster et al.,
2016).
7. Thyroid and sexual orientation
Several experimental findings suggest that in human sexual
orientation genes and hormones play a pivotal role (Jannini et al.,
2010). A recent population-based study on > 5000 Danish homo-
sexuals found a significantly higher frequency of Graves’ disease
when compared to general population, also when excluding men
with HIV or AIDS (Frisch et al, 2014). This has been related to
possible genetic/prenatal mechanisms linking the risk of Graves’
disease with possible genes or genetic markers related to homo-
sexuality carried on the X chromosome (Hu et al., 1995). Interest-
ingly, the mothers of homosexual men are characterized by high
frequency of extreme skewing of X-inactivation (Bocklandt et al.,
2006), a similar high frequency that has been reported in females
with the autoimmune thyroid disease (Brix et al., 2005). The
possible relationship between thyroid and sexual orientation is
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body mass index than heterosexual men, independently of diet or
exercise (Blanchard and Bogaert, 1996; Deputy and Boehmer, 2010;
Frisch and Zdravkovic, 2010). Moreover, homosexual adolescents
more likely have mothers with thyroid dysfunction during preg-
nancy than heterosexuals (Sabuncuoglu, 2015). More recently, a
genome-wide association study of male sexual orientation on a
primarily European ancestry sample of >1000 homosexual men
identified several single nucleotide polymorphisms on chromo-
some 13, in the region on genes expressed in the diencephalon
previously reported as differing in size in men by sexual orientation
(LeVay, 1991) and on chromosome 14 in the thyroid stimulating
receptor locus (Sanders et al., 2017) further indicating a possible
connection between thyroid, thyroid derangements and a subset of
men having sex with men.All together, these findings suggest that
the relationship between genes, thyroid function and male homo-
sexuality would provide, if confirmed by more robust data, new
interesting insights in the biology of male sexual orientation.
8. Conclusion
Many evidences show that alterations in thyroid function can
affect both male and female sexual function. The presence of TRs in
genitals provide the basis onwhich to hypothesize a direct effect of
THs on sexual functions. However, the effect of THs is not only
confined to genitals. In fact several data showed, as in the brain, THs
may affect estrogens in the triggering of desire and libido. More
studies are required to better delineate the real impact of thyroid in
sexual function. Currently, it can be concluded that, despite the
apparent, relative disinterestedness of the large majority of clinical
endocrinologists dealing with thyroid diseases, demonstrated by a
lack of use of psychometric tools designed to discover the presence
of a sexual dysfunction (Corona et al., 2006a). THs strongly affect
the human sexual function at various levels and that the thyroid
gland must be considered, along with the genitals and the brain, a
sexual organ.
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